2024–25 Innovation Challenge winner
RenewRx carries maternal-health innovation beyond the Challenge.
A Regis Innovation Challenge winner is turning the moments between appointments into a more connected model of cardiometabolic care—beginning with pregnancy.
The most important parts of care do not happen only in an exam room. RenewRx is built around that simple idea: people deserve practical, personalized support as they make the everyday decisions that shape health during pregnancy and beyond.
Care that continues between visits
RenewRx is a cardiometabolic care execution platform that starts with pregnancy, a pivotal time for both maternal and long-term health. Its model brings together real-time adherence tracking, nutrition support and clinical escalation alerts to help people act on a care plan in the moments when support is most useful.
The company’s approach is designed to make guidance feel more achievable: one next step, tailored to the person, with a clear connection back to the care team when extra attention is needed. Rather than adding another disconnected health tool, RenewRx is working to make the plan of care easier to carry into daily life.
A winning idea built for real-world use
RenewRx earned the top prize in the 2024–25 Regis Innovation Challenge, recognizing a venture that pairs a meaningful health challenge with a practical path forward. The Challenge gave the team a place to sharpen its story, test its assumptions and connect with mentors and peers who understand that building a venture means continually moving from insight to execution.
That foundation matters in health innovation, where a promising idea has to work not only in theory but within the realities of a patient’s day and a clinical team’s workflow. RenewRx continues to focus on both sides of that equation: helping people build sustainable habits while giving care partners visibility when it can make a difference.
Recognition that opens new doors
Since its Innovation Challenge win, RenewRx has stepped onto larger stages in the health-technology ecosystem. The company graduated from MedTech Innovator, a global accelerator for medical technology companies, and has earned additional industry recognition, including FemTech Product of the Year at the 2025 MedTech Malta Awards.
Those moments are affirmations of momentum, but they are also opportunities: to learn from other builders, strengthen partnerships and bring the RenewRx model to more communities. The Nasdaq billboard celebration captured one milestone; the work behind it is a steady effort to make care more connected and more human.
Growing an impact that begins locally
RenewRx’s progress reflects what the Regis Innovation Challenge is designed to support. A founder can enter with an urgent problem, build alongside a community of mentors and students, and leave with stronger conviction and a clearer path to grow. The goal is not to prescribe one kind of success; it is to help ventures develop the relationships, discipline and confidence that let them keep moving.
For RenewRx, that journey is still unfolding. By starting with pregnancy and looking toward lifelong cardiometabolic health, the team is pursuing an impact that reaches well beyond a single event or award—one centered on helping people and their care teams stay connected when it matters most.